The role of a polycaprolactone stimulator in the facial rejuvenation process

Main Article Content

Ana Lorena Gonzalez-Botello

Keywords

polycaprolactone filler, anti-aging, dermal filler, skin aging

Abstract

Background: Aging is a process that mainly affects human fibroblasts since they have a limited ability to divide. In general, cells lose their proliferative capacity and enter a cell slowdown, also known as cellular senescence. This review focuses on non-surgical techniques for both functional and cosmetic facial rejuvenation, with particular attention to polycaprolactone (PCL) fillers as an effective collagen stimulator. Aim: The aim of this study is to evaluate the efficacy of polycaprolactone stimulators in facial rejuvenation by assessing improvements in skin texture, volume restoration, and overall aesthetic outcomes. Methods: A systematic review was conducted between May 2022 and October 2023, involving a comprehensive analysis of twenty-five articles. Results: The studies presented below, each designed to address various aspects related to PCL dermal fillers, are extensively analyzed, encompassing enhancements in dermal properties, histopathological insights, patient satisfaction and safety, the assessment of potential complications, and combination therapies. Conclusion: PCL is a safe and effective material for skin rejuvenation, and it is a viable choice in the realm of aesthetic and functional enhancements, addressing the perennial quest for youthful and rejuvenated appearances with minimal risks and maximal patient satisfaction.

Abstract 49 | PDF Downloads 86

References

1. Csekes E, Račková L. Skin Aging, Cellular Senescence and Natural Polyphenols. Int J Mol Sci. 2021 23;22(23):12641. doi: 10.3390/ijms222312641.
2. Ko AC, Korn BS, Kikkawa DO. The aging face. Surv Ophthalmol. 2017 Mar-Apr;62(2):190-202. doi: 10.1016/j.survophthal.2016.09.002.
3. Zhang S, Duan E. Fighting against Skin Aging: The Way from Bench to Bedside. Cell Transplant. 2018 May;27(5):729-738. doi: 10.1177/0963689717725755.
4. de Melo F, Nicolau P, Piovano L, Lin SL, Baptista-Fernandes T, King MI, Camporese A, Hong K, Khattar MM, Christen MO. Recommendations for volume augmentation and rejuvenation of the face and hands with the new generation polycaprolactone-based collagen stimulator (Ellansé®). Clin Cosmet Investig Dermatol. 2017 Nov 8;10:431-440. doi: 10.2147/CCID.S145195.
5. Kim J. Isovolemic Degradation of Polycaprolactone Particles and Calculation of Their Original Size from Human Biopsy. Plast Reconstr Surg Glob Open. 2020 Jun 26;8(6):e2866. doi: 10.1097/GOX.0000000000002866.
6. Christen MO, Vercesi F. Polycaprolactone: How a Well-Known and Futuristic Polymer Has Become an Innovative Collagen-Stimulator in Esthetics. Clin Cosmet Investig Dermatol. 2020 Jan 20;13:31-48. doi: 10.2147/CCID.S229054.
7. Lin SL, Christen MO. Polycaprolactone-based dermal filler complications: A retrospective study of 1111 treatments. J Cosmet Dermatol. 2020 Aug;19(8):1907-1914. doi: 10.1111/jocd.13518.
8. Christen MO, Vercesi F. Polycaprolactone: How a Well-Known and Futuristic Polymer Has Become an Innovative Collagen-Stimulator in Esthetics. Clin Cosmet Investig Dermatol. 2020 Jan 20;13:31-48. doi: 10.2147/CCID.S229054.
9. Moon SY, Eun DH, Park JH, Han MH, Jang YH, Lee WJ, Kim DW, Lee SJ. Foreign body reaction three years after injection with polycaprolactone (Ellanse®). Eur J Dermatol. 2017 Oct 1;27(5):549-551. doi: 10.1684/ejd.2017.3089.
10. Kim JS. Changes in Dermal Thickness in Biopsy Study of Histologic Findings After a Single Injection of Polycaprolactone-Based Filler into the Dermis. Aesthet Surg J. 2019 Nov 13;39(12):NP484-NP494. doi: 10.1093/asj/sjz050.
11. Lin SL. Polycaprolactone facial volume restoration of a 46-year-old Asian women: A case report. J Cosmet Dermatol. 2018 Jun;17(3):328-332. doi: 10.1111/jocd.12482.
12. Kim JS, In CH, Park NJ, Kim BJ, Yoon HS. Comparative study of rheological properties and preclinical data of porous polycaprolactone microsphere dermal fillers. J Cosmet Dermatol. 2020 Mar;19(3):596-604. doi: 10.1111/jocd.13076.
13. Hong JY, Kim JH, Kwon TR, Hong JK, Li K, Kim BJ. In vivo evaluation of novel particle-free polycaprolactone fillers for safety, degradation, and neocollagenesis in a rat model. Dermatol Ther. 2021 Mar;34(2):e14770. doi: 10.1111/dth.14770.
14. Kim JA, Van Abel D. Neocollagenesis in human tissue injected with a polycaprolactone-based dermal filler. J Cosmet Laser Ther. 2015 Apr;17(2):99-101. doi: 10.3109/14764172.2014.968586.
15. de Melo F, Marijnissen-Hofsté J. Investigation of physical properties of a polycaprolactone dermal filler when mixed with lidocaine and lidocaine/epinephrine. Dermatol Ther (Heidelb). 2012 Dec;2(1):13. doi: 10.1007/s13555-012-0013-7.
16. Kim J. Tumescent anesthesia for reducing pain, swelling, and ecchymosis during polycaprolactone filler injections in the face. J Cosmet Laser Ther. 2017 Nov;19(7):434-438. doi: 10.1080/14764172.2017.1342037.
17. Bae B, Lee G, Oh S, Hong K. Safety and Long-Term Efficacy of Forehead Contouring With a Polycaprolactone-Based Dermal Filler. Dermatol Surg. 2016 Nov;42(11):1256-1260. doi: 10.1097/DSS.0000000000000913.
18. Moers-Carpi MM, Sherwood S. Polycaprolactone for the correction of nasolabial folds: a 24-month, prospective, randomized, controlled clinical trial. Dermatol Surg. 2013 Mar;39(3 Pt 1):457-63. doi: 10.1111/dsu.12054.
19. Wortsman X, Quezada N. Ultrasound Morphology of Polycaprolactone Filler. J Ultrasound Med. 2017 Dec;36(12):2611-2615. doi: 10.1002/jum.14327.
20. Jeong GJ, Ahn GR, Park SJ, Hong JY, Kim BJ. A randomized, patient/evaluator-blinded, split-face study to compare the efficacy and safety of polycaprolactone and polynucleotide fillers in the correction of crow's feet: The latest biostimulatory dermal filler for crow's feet. J Cosmet Dermatol. 2020 Jul;19(7):1593-1599. doi: 10.1111/jocd.13199.
21. Oh H, Lee S, Na J, Kim BJ, Kim JH. Comparative Evaluation of Physical Characteristics and Preclinical Data of a Novel Monodisperse Polycaprolactone Microspheres Filler. Aesthetic Plast Surg. 2022 Feb;46(1):429-436. doi: 10.1007/s00266-021-02470-6.
22. Yanatma I, Sarac G, Gul M, Gul S, Kapicioglu Y. Comparison of polycaprolactone and calcium hydroxylapatite dermal fillers in a rat model. Dermatol Ther. 2021 Jan;34(1):e14716. doi: 10.1111/dth.14716.
23. Kwon TR, Han SW, Yeo IK, Kim JH, Kim JM, Hong JY, Lee BC, Lee SE, Moon HS, Kwon HJ, Kim BJ. Biostimulatory effects of polydioxanone, poly-d, l lactic acid, and polycaprolactone fillers in mouse model. J Cosmet Dermatol. 2019 Aug;18(4):1002-1008. doi: 10.1111/jocd.12950.
24. Galadari H, van Abel D, Al Nuami K, Al Faresi F, Galadari I. A randomized, prospective, blinded, split-face, single-center study comparing polycaprolactone to hyaluronic acid for treatment of nasolabial folds. J Cosmet Dermatol. 2015 Mar;14(1):27-32. doi: 10.1111/jocd.12126.
25. de Melo F, Carrijo A, Hong K, Trumbic B, Vercesi F, Waldorf HA, Zenker S. Minimally Invasive Aesthetic Treatment of the Face and Neck Using Combinations of a PCL-Based Collagen Stimulator, PLLA/PLGA Suspension Sutures, and Cross-Linked Hyaluronic Acid. Clin Cosmet Investig Dermatol. 2020 May 5;13:333-344. doi: 10.2147/CCID.S248280.